Polaryx Therapeutics, Inc. (PLYX) stock
PLYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$1.61+0.01 (+0.63%)
Close on Nov 18, 2026Market cap $80.25MP/E –Yield –
Polaryx Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Polaryx Therapeutics's total assets was $8.61M at Sep 30, 2026. For fiscal 2025 it was $5.17M, up 3.4% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.17M | +3.4% |
| FY2024 | Dec 31, 2024 | $5.00M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $8.61M | +72.2% |
| Q2 FY2026 | Jun 30, 2026 | $11.81M | – |
| Q1 FY2026 | Mar 31, 2026 | $3.50M | – |
| Q4 FY2025 | Dec 31, 2025 | $5.17M | – |
| Q4 FY2024 | Dec 31, 2024 | $5.00M | – |
See a number that looks wrong?